2m 2m 2m 2m 2m 2m 2m
IMMUNOME (IMNM)
NASDAQ
$27.48-$1.04 (-3.65%)
Price as of Aug 21, 2026 7:30 PM EDT- $3.2BMarket Cap
- 176.89%1-Year Change
- BiotechnologyIndustry
IMMUNOME (IMNM)
$27.48-$1.04 (-3.65%)
IMNM | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $28.52 | ||
Change | +$0.44 (+1.57%) | ||
Open | $28.46 | ||
High | $29.30 | ||
Low | $28.13 | ||
Previous Close | $28.08 | ||
Volume | 848,794 | ||
30-Day Average Volume | 1,091,785 | ||
1-Week Change | 4.85% | ||
1-Month Change | 25.20% | ||
1-Year Change | 176.89% | ||
3-Year Change | 302.82% | ||
5-Year Change | 128.16% | ||
Fundamentals | |||
Shares Outstanding | 113.6M | ||
Total Assets | $565.4M | ||
Market Cap | $3.2B | ||
Enterprise Value | $3.0B | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$73.1M | ||
Free Cash Flow | -$63.9M | ||
EBIT | -$73.1M | ||
EBITDA | -$72.2M | ||
Net Working Capital | $502.7M | ||
EPS | -$0.65 | ||
Enterprise Value/EBITDA | -42 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -44 | ||
PEG | 1 | ||
Price/Free Cash Flow | -51 | ||
Price/Operating Cash Flow | -53 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 1000 | ||
Last Split Date | 12/19/2007 | ||
Earnings & Revenue